Cargando…
Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and β3-adrenoceptor agonists
PURPOSE: To examine the efficacy and safety of non-ablative vaginal erbium:YAG laser (VEL) for the treatment of overactive bladder syndrome (OAB) compared with those of two other common pharmacotherapies, namely, anticholinergics and β3-adrenoceptor agonists. METHODS: Female subjects aged 60–69 year...
Autor principal: | Okui, Nobuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825634/ https://www.ncbi.nlm.nih.gov/pubmed/30687908 http://dx.doi.org/10.1007/s00345-019-02644-7 |
Ejemplares similares
-
Ablative Fractional Erbium:YAG Laser Resurfacing: A Treatment Option for Acne
por: Guida, Stefania, et al.
Publicado: (2022) -
Comparison of urethral sling surgery and non-ablative vaginal Erbium:YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis
por: Okui, Nobuo, et al.
Publicado: (2021) -
Argon laser versus erbium:YAG laser in the treatment of xanthelasma palpebrarum
por: Abdelkader, Mona, et al.
Publicado: (2015) -
Percutaneous Bone Marrow Transplantation Using Fractional Ablative Erbium:YAG Laser
por: Rodriguez-Menocal, Luis, et al.
Publicado: (2014) -
Novel Management of Rhinophyma by Patterned Ablative 2940nm Erbium:YAG Laser
por: Badawi, Ashraf, et al.
Publicado: (2020)